Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?

Annals of Surgery

Volumn 247, Issue 2, 2008, Pages 320-326

  Ganter, Michael T ^a,d   Cohen, Mitchell J ^b   Brohi, Karim ^c   Chesebro, Brian B ^a   Staudenmayer, Kristan L ^b   Rahn, Pamela ^b   Christiaans, Sarah C ^a   Bir, Natasha D ^b   Pittet, Jean François ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; COMPLEMENT; PROTEIN C;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; COMPLEMENT ACTIVATION; DISEASE MARKER; DISEASE SEVERITY; EARLY DIAGNOSIS; EMERGENCY WARD; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FLUID RESUSCITATION; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PENETRATING TRAUMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADULT; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEX FACTORS; TRAUMA SEVERITY INDICES; VASOCONSTRICTION; WOUNDS AND INJURIES;

EID: 38549109998     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318162d616     Document Type: Article

References (50)

1. Injury Chart Book, World Health Organization. 2002. Available at: http://www who int/violence_injury_prevention/publications/other_injury/chartb/ en/index html. Accessed September 12, 2006.
2. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60:S3-S11.
3. Ikegami K, Suzuki Y, Yukioka T, et al. Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma. J Trauma. 1998;44:789-794.
4. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care. 2003;7:130-138.
5. Flori HR, Ware LB, Milet M, et al. Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med. 2007;8:96-101.
6. Ware LB, Eisner MD, Thompson BT, et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med. 2004;170:766-772.
7. Koh GY, Kim I, Kwak HJ, et al. Biomedical significance of endothelial cell specific growth factor, angiopoietin. Exp Mol Med. 2002;34:1-11.
8. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
9. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006;27:552-558.
10. Bouis D, Kusumanto Y, Meijer C, et al. A review on pro- and antiangiogenic factors as targets of clinical intervention. Pharmacol Res. 2006;53:89-103.
11. Rondaij MG, Bierings R, Kragt A, et al. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26:1002-1007.
12. Parikh SM, Mammoto T, Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006;3:e46.
13. Orfanos SE, Kotanidou A, Glynos C, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med. 2007;35:199-206.
14. Bhandari V, Choo-Wing R, Lee CG, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12:1286-1293.
15. Huang YQ, Li JJ, Hu L, et al. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood. 2002;99:1646-1650.
16. Oh H, Takagi H, Suzuma K, et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem. 1999;274:15732-15739.
17. Mandriota SJ, Pyke C, Di SC, et al. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol. 2000;156:2077-2089.
18. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion, modulated through the protein C pathway? Ann Surg. 2007;245:812-818.
19. Ganter MT, Brohi K, Cohen MJ, et al. Role of the alternative pathway in the early complement activation following major trauma. Shock. 2007;28:29-34.
20. Baker SP, O'Neill B, Haddon W Jr, et al. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
21. Rutherford EJ, Morris JA Jr, Reed GW, et al. Base deficit stratifies mortality and determines therapy. J Trauma. 1992;33:417-423.
22. Davis JW, Parks SN, Kaups KL, et al. Admission base deficit predicts transfusion requirements and risk of complications. J Trauma. 1996;41:769-774.
23. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
24. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204-R212.
25. Reinhart K, Bayer O, Brunkhorst F, et al. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 2002;30:S302-S312.
26. Wang P, Ba ZF, Chaudry IH. Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am J Physiol. 1993;265:H973-H979.
27. Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Ann Surg. 1999;229:121-127.
28. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279-367.
29. Peters KG, Kontos CD, Lin PC, et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res. 2004;59:51-71.
30. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006;312:630-641.
31. Roviezzo F, Tsigkos S, Kotanidou A, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005;314:738 -744.
32. Gale NW, Thurston G, Hackett SF, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell. 2002;3:411-423.
33. Vischer UM, Jornot L, Wollheim CB, et al. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Blood. 1995;85:3164-3172.
34. Levine JD, Harlan JM, Harker LA, et al. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood. 1982;60:531-534.
35. Hattori R, Hamilton KK, McEver RP, et al. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem. 1989;264:9053-9060.
36. Matsushita K, Yamakuchi M, Morrell CN, et al. Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis. Blood. 2005;105:207-214.
37. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 1991;65:618-623.
38. Kaner RJ, Ladetto JV, Singh R, et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000;22:657-664.
39. van der FM, van Leeuwen HJ, van Kessel KP, et al. Plasma vascular endothelial growth factor in severe sepsis. Shock. 2005;23:35-38.
40. Pickkers P, Sprong T, Eijk L, et al. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock. 2005;24:508-512.
41. Grad S, Ertel W, Keel M, et al. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med. 1998;36:379-383.
42. Infanger M, Schmidt O, Kossmehl P, et al. Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. Burns. 2004;30:305-311.
43. Godzich M, Hodnett M, Frank JA, et al. Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J. 2006;20:1519-1521.
44. Kanellis J, Paizis K, Cox AJ, et al. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression. Kidney Int. 2002;61:1696-1706.
45. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132:620-624.
46. Sauaia A, Moore FA, Moore EE, et al. Early predictors of postinjury multiple organ failure. Arch Surg. 1994;129:39-45.
47. Ciesla DJ, Moore EE, Johnson JL, et al. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg. 2005;140:432-438.
48. Beck H, Acker T, Wiessner C, et al. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol. 2000;157:1473-1483.
49. Lip PL, Chatterjee S, Caine GJ, et al. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol. 2004;88:1543-1546.
50. Koga K, Todaka T, Morioka M, et al. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res. 2001;61:6248-6254.